Flower Mound, TX
Stem Cell Therapy clinics in Flower Mound
Stem cell and cell-based therapy in Flower Mound is a closely watched regulatory space. FDA-approved stem cell products (hematopoietic, select cord blood) are delivered at academic centers tied to Texas Health Presbyterian Flower Mound. The vast majority of cash-pay stem cell offerings, mesenchymal, adipose-derived, amniotic, exosomes, are not FDA approved. Demand reflects an affluent north Dallas suburban family base.
The FDA has aggressively pursued clinics marketing unapproved stem cell products for orthopedic, neurologic, and autoimmune indications. Clinics in Flower Mound, Texas operating in this space should be evaluated carefully for informed consent, product sourcing, and honest evidence framing. Texas rules on infusion delegation and medspa physician medical director requirements shapes enforcement posture.
With stem cell clinics on Regenerated.com in Flower Mound, patients can compare product type, FDA status, clinician credentials, and whether the clinic is enrolling in registered trials or operating outside them.
Health Resource Center
- Vitamin IV Therapy
- Biofeedback Therapy
- Ozone Therapy
- IV Therapy
- Oxygen Therapy
Regulatory context
A note on Texas's stem cell therapy rules.
Texas cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in Texas for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. Texas enacted a state-level investigational adult stem cell framework in 2017 that does not override federal law.
-
Texas HB 810 (2017), Texas Health and Safety Code Chapter 1003
Authorizes administration of investigational adult stem cell treatments to eligible patients with severe chronic or terminal illness when conducted by Texas-licensed physicians at facilities meeting defined institutional review board oversight criteria. -
Texas Medical Practice Act, Texas Occupations Code Title 3, Subtitle B
Establishes physician licensure and discipline through the Texas Medical Board. -
Texas Pharmacy Act, Texas Occupations Code Chapter 551 et seq
Regulates compounding pharmacies aligned with federal 503A and 503B standards.
The FDA has issued warning letters to Texas clinics offering stem cell and exosome therapies. The Texas Medical Board has disciplined physicians for unprofessional conduct including misleading regenerative medicine advertising. The Texas Attorney General has used the Texas Deceptive Trade Practices Act to pursue providers making unsupported clinical claims. HB 810 expressly does not preempt federal law, so even Texas providers operating under HB 810 must comply with 21 CFR Part 1271 and remain subject to FDA enforcement if products fall outside Section 361.